Challenges of the Unknown: Clinical Application of Microbial Metagenomics

Availability of fast, high throughput and low cost whole genome sequencing holds great promise within public health microbiology, with applications ranging from outbreak detection and tracking transmission events to understanding the role played by microbial communities in health and disease. Within...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of genomics Vol. 2015; no. 2015; pp. 1 - 10
Main Authors Misra, Raju V., Mee, Edward T., Anscombe, Catherine, Wooldridge, David J., Rose, Graham, Gharbia, Saheer
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Publishing Corporation 01.01.2015
John Wiley & Sons, Inc
Wiley
Subjects
Online AccessGet full text
ISSN2314-436X
2314-4378
DOI10.1155/2015/292950

Cover

More Information
Summary:Availability of fast, high throughput and low cost whole genome sequencing holds great promise within public health microbiology, with applications ranging from outbreak detection and tracking transmission events to understanding the role played by microbial communities in health and disease. Within clinical metagenomics, identifying microorganisms from a complex and host enriched background remains a central computational challenge. As proof of principle, we sequenced two metagenomic samples, a known viral mixture of 25 human pathogens and an unknown complex biological model using benchtop technology. The datasets were then analysed using a bioinformatic pipeline developed around recent fast classification methods. A targeted approach was able to detect 20 of the viruses against a background of host contamination from multiple sources and bacterial contamination. An alternative untargeted identification method was highly correlated with these classifications, and over 1,600 species were identified when applied to the complex biological model, including several species captured at over 50% genome coverage. In summary, this study demonstrates the great potential of applying metagenomics within the clinical laboratory setting and that this can be achieved using infrastructure available to nondedicated sequencing centres.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Inna Dubchak
ISSN:2314-436X
2314-4378
DOI:10.1155/2015/292950